This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Express Scripts Acquires SmartD Medicare Prescription Drug Plan; Adds To Industry-Leading Medicare Offering





ST. LOUIS, Sept. 9, 2013 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) today announced the strategic acquisition of the SmartD Medicare Prescription Drug Plan (PDP) which will add 87,000 covered Medicare lives. Terms of the deal were not disclosed.

(Logo: http://photos.prnewswire.com/prnh/20080827/EXPRESSSCRIPTSLOGO)

"Working together with independent and chain pharmacies, we look forward to serving SmartD members and we are pleased in the continued growth and enhancement of our Medicare PDP offering," said Brit Pim, vice president and general manager, government programs at Express Scripts. "We are proud of our track record of success in administering Medicare prescription drug plans and that's due to our expertise in and commitment to member service."

Express Scripts serves millions of Medicare beneficiaries on behalf of our health plans, our Employer Group Waiver Plan (EGWP) clients as well as through our own national Express Scripts Medicare PDP, which has consistently earned high Center for Medicare Services (CMS) Star Ratings. In 2013, the plan earned four out of five possible stars – the highest of any nationally offered PDP.**

"We have the right people and processes to ensure Express Scripts consistently delivers advanced health and safety solutions, driven by a compliance-first culture, to meet the needs of the Medicare marketplace," said Pim. "We're committed to continuing investing in this area, developing and expanding programs that help Medicare beneficiaries and plan sponsors make better decisions and realize healthier outcomes."

Express Scripts Medicare Advisors and pharmacists are available 24 hours a day/7 days a week to help lower costs, alert beneficiaries to the Coverage Gap and offer guidance on ways to delay reaching it.



**A 2013 4-star-rated plan in 49 states and 3.5 stars in NY. Plan performance summary star ratings are assessed each year and may change from one year to the next.



1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs